Shares in West Perth-registered cloud and software provider Dropsuite surged 30 per cent after a bid to acquire the company by US SaaS provider NinjaOne.
Telstra will cut its data and AI provider list down to just two as part of a proposed joint venture with Accenture which will also see 726 jobs migrate to the JV.
The coast-to-coast connection spans from Brisbane to Perth, and will offer data transfer speeds of up to 400 gigabits per second on a single optical wavelength.
Laurence Escalante could more than double his stake in AI-driven surveillance company icetana and become its largest shareholder, as the company gears up to enter Iraq.
Kim Beazley-backed medtech company Orthocell has flagged an expedited expansion into several jurisdictions after strong early sales of its Remplir nerve repair technology.
CyberCX is calling for consumer protections on Chinese smart devices, following an investigation into a hacked doorbell in an Australian house, which allowed an attacker to monitor video feeds.
Qoria's innovative integration of AI products for child cyber safety has resulted in a 30 per cent growth in annual recurring revenue in the US and Oceanic markets.
The 2025 iteration of PwC’s Global CEO survey has found the slow adoption of AI in the workplace and the inflation fight are the two largest concerns for Australian executives.
Singular Health has announced its memorandum of understanding with US-based Provider Network Solutions has moved to its next phase, due to a successful proof of concept.
Hazer Group, the cleantech spinout of research from the University of Western Australia, has been granted a patent by the Japanese Patent Office for a novel process of producing hydrogen.
Murdoch-based regenerative medicine company Orthocell has posted its third consecutive quarter of record revenue, as it gears up for a final approval from the US FDA for its Remplir nerve product.
Australians are likely to see more false content and abuse on their Facebook, Instagram and Threads feeds when Meta ditches fact-checking problematic posts.
Plug-in hybrid electric vehicle sales have more than doubled in the past year in Western Australia, while diesel, petrol and electric vehicles have all slumped in sales.
The time it takes to correctly diagnose endometriosis could be slashed from seven years to just a few weeks with a new, non-invasive test from Nedlands-based Proteomics International.
Orthocell has submitted its application for US Food and Drug Administration approval for its Remplir nerve regeneration product, marking another moment in a year full of milestones.
Members of WA’s start up community are calling for a $100 million commitment to extend the New Industries Fund beyond 2025, warning a failure to do so risked WA falling behind other states.
ASX-listed Botanix has shipped the first batch of Sofdra prescriptions, marking a milestone moment as it shifts towards becoming a revenue generating pharmaceuticals company.
A novel skin cancer diagnosis tool which was a finalist in Pilbara Health Challenge has been validated for the first time in humans, meaning skin biopsies could become a thing of the past.
The WA government backed AROSE consortium has missed out on the chance to build Australia’s first lunar rover, with the $42 million contract going to eastern states based ELO2.
The federal government says a plan to grow investment in AI will be released by the end of 2025, despite experts warning Australia is already falling behind in the AI race.
Tech giants with Australian revenue of more than $250 million will be pushed to pay for news from Australian outlets via a new incentive scheme announced today.
